Development of Consensus Recommendations on the Management of Vitiligo and the Role of Decapeptide in Vitiligo by the Delphi Method

Author:

Parsad Davinder,Kandhari Sanjeev,Dhurat Rachita,Shah Bela,Majid Imran,Yadalla Harikishan Kumar,Sakhiya Jagdish,Poojary Shital,Jagadish P.,Banotkar Pravin D.,Babu Ravindra,Shivakumar Y. M.,Bose S. K.,Jamadar Saleem,Shah Monal,Tank Bharat,Dhabhai Ravindra,Mittal Sanjay Kumar,Bhushan Premanshu,Pandita Akshi,Barve Vaibhav

Abstract

Background: Treatment of vitiligo is still a challenge in dermatology. Literature is sparse on the definitive clinical role of basic fibroblast growth factor (bFGF) in vitiligo patients. Aims: We decided to generate a consensus in an attempt to answer some critical questions related to the management of vitiligo and the role of bFGF. Materials and Methods: A Delphi method among 21 experts across India was conducted. A consensus (agreement was 75% or greater) was taken on 27 statements on the prevalence, epidemiology, and treatment of vitiligo and the role of bFGF in the management of vitiligo. The consensus process was completed after two rounds. Results: Topical corticosteroid therapy is the first-line therapy for vitiligo; however, its adverse effects are widely known, especially in sensitive areas. Topical calcineurin inhibitors are preferred in stable vitiligo of the face, neck, genitals, or intertriginous regions as an alternative to topical corticosteroids. Topical bFGF is a relatively newer therapy with a promising role in stable vitiligo. bFGF is safe and effective in inducing repigmentation of vitiligo lesions. Combination therapy of bFGF with other topical therapies, phototherapy, and surgical procedures can be beneficial in patients of vitiligo. Conclusion: This consensus would complement the currently available literature on bFGF and help the practitioner to recognize the unmet need in the treatment of vitiligo.

Publisher

Medknow

Reference41 articles.

1. Vitiligo: A Review;Bergqvist;Dermatology,2020

2. Basic Fibroblast Growth Factor (bFGF) related decapeptide 0.1% Solution, with Tacrolimus 0.1% ointment combination therapy compared with Tacrolimus 0.1% ointment monotherapy in the treatment of stable vitiligo: A Phase IV, randomized 12 months Study;Parsad;IP Indian J Clin Exp Dermatol,2020

3. A Double Blind Randomized Phase IV Clinical Trial of basic Fibroblast Growth Factor Related Deca-peptide in Vitiligo;Ramaiah;Pigmentary Disorders S,2015

4. Vitiligo: Compendium of clinico-epidemiological features;Sehgal;Indian J Dermatol Venereol Leprol,2007

5. Segmental vitiligo: Clinical findings in 208 patients;Hann;J Am Acad Dermatol,1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3